Scinai Immunotherapeutics (Scinai BioServices)

Israeli CDMO (Jerusalem) focused on biologics — recombinant proteins, antibodies, and aseptic fill/finish. Provides end-to-end development and manufacturing from early research through Phase 3 clinical trials in a cGMP facility with over 20 years of experience. Note: primarily a biologics CDMO; peptide manufacturing is not a current published offering.

Directory assessment: Scinai Immunotherapeutics (Scinai BioServices) is listed as a CDMO in the peptide supply chain, serving Asia markets from Israel (Jerusalem). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 1 source for reference. This supplier has a moderate confidence score — buyers should perform additional due diligence before engaging.